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Abstract
The cellular adaptive immune response plays a key role in resolving influenza infection.
Experiments where individuals are successively infected with different strains within a
short timeframe provide insight into the underlying viral dynamics and the role of a
cross-reactive immune response in resolving an acute infection. We construct a math-
ematical model of within-host influenza viral dynamics including three possible factors
which determine the strength of the cross-reactive cellular adaptive immune response:
the initial naive T cell number, the avidity of the interaction between T cells and the
epitopes presented by infected cells, and the epitope abundance per infected cell. Our
model explains the experimentally observed shortening of a second infection when cross-
reactivity is present, and shows that memory in the cellular adaptive immune response
is necessary to protect against a second infection.
Keywords: mathematical model, viral dynamics, immunology, cytotoxic T lymphocyte
1. Introduction
The immune response plays an important role in the resolution of primary acute
influenza infection and prevention of subsequent infection in an individual. It can be
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divided broadly into three parts: the innate immune response, which is fast-acting and
non-specific in that it protects the host against a wide range of pathogens (Kreijtz et al.,
2011); the humoral adaptive immune response, which is slower-acting but required to
clear infection (Iwasaki & Nozima, 1977); and the cellular adaptive immune response,
which shortens infection and prevents severe disease (Sridhar et al., 2013).
The adaptive immune response is antigen-specific. The host has a diverse repertoire
of B cells (for the humoral response) and T cells (for the cellular response); these target
short peptide fragments, or epitopes, presented by infected cells and professional antigen-
presenting cells (Rammensee et al., 1993). Only B cells and T cells specific to presented
epitopes are stimulated by infection, and the protective effects of the adaptive immune
response, such as neutralisation of infectious virus and lysis (killing) of infected cells,
are directed at those viral epitopes. In practice, the immune response to a pathogen is
directed at a small number of epitopes, which are termed immunodominant (Yewdell &
Bennink, 1999). Cross-reactivity in the adaptive immune response occurs when epitopes
are shared between virus strains, such that B cells and T cells stimulated by one virus
strain can protect against infection with another.
Although antibodies form the first line of defence in protection against influenza
infection, immunodominant epitopes targeted by the humoral adaptive immune response
appear on the hemagglutinin and neuraminidase proteins, surface proteins which rapidly
mutate between strains, such that individuals with previous immunity are no longer
immune to the mutated strain (Brown & Kelso, 2009). As a result, in the very common
occurrences of antigenic drift and antigenic shift which respectively result in epidemics
and pandemics, significant evidence is accumulating to suggest that CD8+ T cells play
a critical protective role. This is by virtue of the fact that immunodominant epitopes
targeted by the cellular adaptive immune response are typically found in internal viral
proteins, which are highly conserved between different influenza A subtypes (Braciale,
1977; Kees & Krammer, 1984; Yewdell et al., 1985; Komadina et al., 2016). Consequently,
cross-reactive memory T cells which remain from previous influenza A infections can be
re-activated upon subsequent infection with other influenza A viruses.
In humans, T cells which are cross-reactive between different influenza A subtypes
have been detected (Jameson et al., 1999; Boon et al., 2004; Greenbaum et al., 2009). The
capacity to induce a strong cellular adaptive immune response (McElhaney et al., 2006),
the presence of cross-reactive T cells (McMichael et al., 1983) and previous influenza A
infection (Epstein, 2006) are all correlated with protection against subsequent infection,
as reviewed by Tscharke et al. (2015). In the context of the 2009 A(H1N1) influenza pan-
demic, where individuals had no pre-existing cross-reactive antibodies, disease severity
was inversely correlated with the frequency of cross-reactive T cells (Sridhar et al., 2013).
However, direct causal evidence for protection from infection due to cross-reactive T cells
is limited in human studies. Animal studies provide an opportunity to directly observe
the impact of recent previous infections on a subsequent infection, including investigation
of the role of the cross-reactive cellular adaptive immune response.
Mice infected with influenza A viruses (H3N2 and/or H1N1), then exposed to a
virulent H7N7 strain cleared the H7N7 infection more quickly than naive mice, and this
was shown to be mediated by the recall of virus-specific CD8+ T cell memory (Christensen
et al., 2000). Ferrets recently infected with a seasonal strain of influenza A, then exposed
to a pandemic strain, had reduced symptoms and viral loads compared to ferrets without
prior exposure (Bodewes et al., 2011); similar results were found in guinea pigs regarding
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reduced viral load and transmission (Steel et al., 2010). Laurie et al. (2010) further
showed that two prior infections were more effective than one at preventing infection and
onward transmission.
Natural infection with influenza in humans is typically separated by a period of years;
on the other hand, animal experiments can be conducted where infections are separated
by days, leading to the observation of viral interference, where very recent/ongoing infec-
tion with a first strain impacts the time course of infection with a second strain. These
studies provide an opportunity to observe the effect of the cross-reactive cellular adap-
tive immune response. Our recent experimental study (Laurie et al., 2015) showed that
when ferrets are inoculated with two influenza strains with a 1–14 day interval sepa-
rating the two exposures, the second infection can be delayed, prevented, or shortened
by the presence of the first infection. The experimental data showed that the effects of
this temporary immunity depended not only on the interval between exposures to the
two viruses, but also on the strains used; delay and prevention of the second infection
were observed whether the two infections were with different types of influenza virus (A
and B) or different subtypes of influenza A, but shortening of the second infection was
only observed for infection with different subtypes of influenza A. We have previously
developed within-host viral dynamics models that demonstrated how the innate immune
response could be responsible for a delayed or prevented second infection (Cao et al.,
2015). Those models were then extended by incorporating the cellular adaptive immune
response to investigate the relationship between CD8+ T cells and recovery time (Cao
et al., 2016). However, due to its focus on primary viral infection, the model by Cao et al.
(2016) included neither the formation of memory T cells nor cross-reactivity of memory
T cells for serologically distinct influenza strains, leaving the effect of those factors on
secondary viral infection unexplored.
Within-host viral dynamics models for the cellular adaptive immune response to mul-
tiple infections have been developed for a range of pathogens. For example, in the case
of homologous challenge with lymphocytic choriomeningitis virus, Chao et al. (2004)
showed that the peak viral load and the recovery time are reduced for the second in-
fection due to the formation of a large pool of memory T cells after primary infection.
The model included the generation of a T cell repertoire through thymic selection, and
allowed for avidity to vary between T cells. However, the model did not extend to mul-
tiple viral strains, and cannot be directly applied to influenza infection due to the lack
of an antibody response. An influenza model by Zarnitsyna et al. (2016) showed that a
second infection is shortened by the presence of resident T cells and/or central memory T
cells; however, this study assumes complete cross-reactivity between the two exposures.
Other within-host influenza dynamics models of cross-reactive cellular adaptive immu-
nity have focused on the emergence of an immunodominance hierarchy for a primary
infection (Luciani et al., 2013), and how decreased viral load during a second infection
changes the immunodominance hierarchy (Handel & Antia, 2008), rather than focusing
on infection outcomes. However, these models did not include the innate or humoral
adaptive immune response, and did not model the formation of memory T cells.
In this work, we develop a viral dynamics model for cross-reactive cellular adaptive
immune responses induced by multiple infections, including the formation of memory T
cells. We examine three factors for changing the strength of the cross-reactive immune
response:
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1. Changing the precursor frequency (initial number) of epitope-specific CD8+ T cells;
2. Changing the avidity of the interaction between CD8+ T cells and the peptide-
MHC complex (pMHC) which presents the epitope;
3. Changing the epitope abundance per infected cell (the number of epitope-specific
pMHC on the surface of the cell).
We use the model to explain the observation by Laurie et al. (2015) that a shortened
second infection only occurs when infection is with heterosubtypic influenza A strains,
and only at inter-exposure intervals of sufficient length for memory in the cellular adaptive
immune response to develop. The results show that under the assumption of negligible
cross-reactivity in the humoral adaptive immune response, both cross-reactivity in the
cellular adaptive immune response and the formation of a memory CD8+ T cell pool
are required to reproduce this shortening of the second infection. We also examine the
boosting of the immune response due to multiple infections which induce cross-reactive
immune responses.
The model for the cellular adaptive immune response is integrated into a viral dynam-
ics model which also includes the innate and humoral adaptive immune responses. There
are a large number of existing within-host influenza viral dynamics models which well
describe the viral load for a single infection, but disagree on the importance of different
components of the immune response (as reviewed by Smith & Perelson (2011); Beau-
chemin & Handel (2011); Dobrovolny et al. (2013)), due to identifiability issues which
arise when fitting such models to viral load data from a single infection (Smith et al.,
2010; Miao et al., 2011; Boianelli et al., 2015). Knockout experiments, where some com-
ponents of the immune response are removed by genetic modification, provide one way
to quantify the components of the immune response separately; our recent study (Cao
et al., 2016) developed a model which reproduces the viral dynamics of three knockout
experiments which removed CD8+ T cell and/or antibody responses (Kris et al., 1988;
Iwasaki & Nozima, 1977). The model in our current study is based on this previous
model, but includes the formation of memory CD8+ T cells as well as multiple pools
of CD8+ T cells which are used to model cross-reactivity between strains. Although
successive infections within a short timeframe rarely arise in natural infection, experi-
ments on this short timeframe allow us to change the initial conditions of the second
infection by changing the inter-exposure interval. This enables independent assessment
of the impact of effector and memory CD8+ T cell subsets which are generated during
distinct time periods after infection, as well as distinction of the roles of the early innate
immune response and subsequent adaptive immune response.
2. Materials and Methods
2.1. The model
We model infection by Q influenza strains and the cellular adaptive immune response
to J epitopes across the Q strains. The dynamics of the multi-strain model (Fig. 2A)
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are described by a set of ordinary differential equations:
dT
dt
= gT
(
1− T +
∑Q
q=1 Iq
T0
)
−
Q∑
q=1
βqVqT (1a)
dF
dt
=
Q∑
q=1
pFqIq − δFF (1b)
dIq
dt
= βqVqT −
δIq + κNqF + J∑
j=1
(κEjqEj + κEˆjqEˆj)
 Iq, q = 1, . . . , Q (1c)
dVq
dt
= pV qIq − (δV q + κAqAq + βqT )Vq. (1d)
When target cells (T ) are infected by virions of strain q (Vq), they become infected
cells (Iq) which produce virions of the same strain. Both infected cells and virions decay
at a constant rate, in addition to infected cell death mediated by natural killer cells and
effector CD8+ T cells (also known as CTL), and virion neutralisation due to antibodies.
The model assumes that the total number of cells is constant, such that
(
1− T+
∑Q
q=1 Iq
T0
)
is the proportion of dead cells; target cells are then replenished at a rate proportional
to the product of the number of uninfected cells and dead cells (Hancioglu et al., 2007).
Cao et al. (2015) modelled three possible mechanisms for the innate immune response,
but as the present study concentrates on the cellular adaptive immune response, we use
one innate immune mechanism only (mechanism 3 in Cao et al. (2015)), namely natural
killer cells which kill infected cells. We note that the qualitative results presented in
this study are unchanged if a different innate immune mechanism is chosen (results not
shown). We assume that natural killer cells are present in proportion to type I interferon
(F ), which is produced in response to infected cells. Effects of natural killer cells other
than cytolysis (such as production of type II interferon) are not modelled, but may be
included in future studies.
The model also captures the role of antibodies (Aq), responsible for strain-specific
viral clearance and induction of long-term sterilising immunity (Fig. 2B). We assume
that any cross-reactive humoral immunity between the strains plays a subdominant part
in the immune response (Terajima et al., 2013; Grebe et al., 2008), such that there is a
one-to-one correspondence between antibodies and the strains upon which they act. The
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equations which describe the production of antibodies are given by Eq. 2:
dB0q
dt
= − Vq
kBq + Vq
βBqB0q (2a)
dB1q
dt
=
Vq
kBq + Vq
βBqB0q − nBqB1q
τBq
− δBqB1q (2b)
dBiq
dt
=
nBq(2Bi−1,q −Biq)
τBq
− δBqBiq, i = 2, ..., nB (2c)
dPq
dt
=
2nBqBnB ,q
τBq
− δBqPq (2d)
dAq
dt
= pAqPq − δAqAq. (2e)
The stimulation of naive B cells (B0q) takes the form of a saturating function, as
shown in Eq. 2a. Once stimulated, naive B cells become plasmablasts (Biq where i de-
notes the stage of plasmablast) (Minges Wols, 2015), as shown in Eq. 2b. In Eqs. 2b and
2c, the plasmablasts undergo programmed proliferation for time τBq, passing through
nBq divisions/stages, until reaching the terminal stage – plasma cells (Pq). The prolifer-
ation process can alternatively be modelled using delay differential equations, where the
equivalent number of plasma cells appears after some delay (Cao et al., 2016); the two
models give qualitatively similar results, but the ordinary differential equation approach
here makes the divisions explicit. Plasma cells (Pq) produce antibodies (Aq) which bind
to virions and neutralise them. Plasmablasts can also produce antibodies, but at a lower
rate (Minges Wols, 2015), which we neglect in our model.
The cellular adaptive immune response, which is responsible for lysis of infected cells
by effector CTL (Fig. 2C), is described in Eqs. 3 and 4. Eq. 3 describes the proliferation
and differentiation of naive CD8+ T cells into effector CTL and the subsequent formation
of memory CD8+ T cells.
dCj
dt
= −
∑Q
q=1 Iq/kCjq
1 +
∑Q
q=1 Iq/kCjq
βCjCj (3a)
dE1j
dt
=
∑Q
q=1 Iq/kCjq
1 +
∑Q
q=1 Iq/kCjq
βCjCj − (nEj
τEj
+ δEj)E1j (3b)
dEij
dt
=
nEj(2Ei−1,j − Eij)
τEj
− δEjEij , i = 2, ..., nE − 1 (3c)
dEnEj
dt
=
2nEjEnE−1,j
τEj
− δEjEnEj (3d)
Ej =
nE∑
i=1
Eij (3e)
dMj
dt
= jδEjEnEj + ˆjδEˆjEˆnEˆj − δEjMj −
Mj
τMj
. (3f)
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We assume that there are J pools of naive CD8+ T cells, and that each of these
recognises a single viral epitope, although it is possible for cells infected with different
strains to present the same epitope. The value for J sufficient to model specific viruses
is virus-dependent. For example, if the cellular adaptive immune response is completely
cross-reactive between strains, a single CD8+ T cell pool (J = 1) may be sufficient; for
partial cross-reactivity, at least three CD8+ T cell pools are required.
We assume that within each pool, all CD8+ T cells are identical; the possibility
that pools may consist of CD8+ T cells with different responsiveness to the epitope is
discussed in Section 4. Epitopes are presented to CD8+ T cells by MHC class I molecules
on the surface of either directly infected cells or on the surface of dendritic cells that have
taken up the antigen and cross-presented it. Cross-presentation can greatly influence the
overall level of epitope presentation in influenza infection (Crowe et al., 2003), but under a
common modelling assumption (see e.g. Chao et al. (2004)) that both direct presentation
and cross-presentation are proportional to the number of infected cells, the model need
not explicitly model cross-presentation.
Naive CD8+ T cell pool j (Cj) is stimulated by interaction with the pMHC, as shown
in Eq. 3a; the stimulation function is a saturating function, such that kCjq is the number
of cells infected with strain q required for (direct- and cross-) presentation of epitopes
which yields half-maximal stimulation of the cellular adaptive immune response (De Boer
et al., 2001; Davenport et al., 2002; Chao et al., 2004). Once stimulated, naive CD8+
T cells divide to become effector CTL of the first stage (E1j), as shown in Eq. 3b;
the effector cells then undergo programmed proliferation (Kaech & Ahmed, 2001; van
Stipdonk et al., 2001; Wodarz & Thomsen, 2005) for time τEj , passing through nEj
divisions, as shown in Eqs. 3b, 3c and 3d. The subscript i denotes the stage of effector
CTL (1 to nEj).
When effector CTL reach their last stage (the dynamics of which are described by
Eq. 3d), they no longer divide; instead, some fraction j survive to become memory
CD8+ T cells (Mj). These memory CD8
+ T cells are refractory in the sense that they
cannot be restimulated for some time (Kaech et al., 2002), which we model as expo-
nentially distributed with mean τMj . After this time, the memory CD8
+ T cells can be
restimulated, and we relabel them Cˆj , where ( ˆ ) indicates memory. Upon restimulation,
memory CD8+ T cells once again become effector CTL Eˆj , which can become refractory
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memory CD8+ T cells Mj ; the process is the same as in Eq. 3.
dCˆj
dt
=
Mj
τMj
−
∑Q
q=1 Iq/kCˆjq
1 +
∑Q
q=1 Iq/kCˆjq
βCˆjqCˆj (4a)
dEˆ1j
dt
=
∑Q
q=1 Iq/kCˆjq
1 +
∑Q
q=1 Iq/kCˆjq
βCˆjqCˆj − (
nEˆj
τEˆj
+ δEˆj)E1jˆ (4b)
dEˆij
dt
=
nEˆj(2Eˆi−1,j − Eˆij)
τEˆj
− δEˆjEˆij , i = 2, ..., nEˆ − 1 (4c)
dEˆnEˆj
dt
=
2nEˆjEˆnEˆ−1,j
τEˆj
− δEˆjEˆnEˆj (4d)
Eˆj =
nEˆ∑
i=1
Eˆij . (4e)
All effector CTL, E and Eˆ, kill infected cells according to the law of mass ac-
tion (Nowak & Bangham, 1996), at rates κEjq and κEˆjq respectively. Unlike antibodies,
effector CTL are not lost during the binding and killing process.
The number of cells infected with strain q required for half-maximal stimulation of
naive CD8+ T cells from pool j, kCjq, and the lysing rate of cells infected with strain
q by effector CTL from pool j, κEjq, are both measures of cross-reactivity. We model
kCjq and κEjq as functions of the avidity of the T cell-pMHC interaction, aj , and the
epitope abundance per infected cell, djq (see Fig. 1); these will be elaborated upon in
Section 3.2. We assume that the killing rate is directly correlated with both avidity
and epitope abundance, while the number of infected cells required for half-maximal
stimulation is inversely correlated with avidity and epitope abundance. Hence,
kCjq =
k˜C
ajdjq
(5a)
κEjq = κ˜Eajdjq (5b)
where k˜C and κ˜E are baseline values (similar equations hold for the memory ( ˆ ) versions
of these parameters).
2.2. Model parameters and solution
In Section 3.2, to model immune responses of different strengths, we vary kC and kCˆ ,
the number of infected cells for half-maximal stimulation of naive and memory CD8+
T cells respectively. We will also vary κE and κEˆ , the lysing rate of infected cells by
effector CTL which originate from naive and memory CD8+ T cells respectively. All
other parameters are chosen to be identical for all strains. These parameters are listed
in Tables 1, 2 and 3. The initial values which are the same between the strains are listed
in Table 4. In addition, we define a baseline value C˜(0) for the initial number of naive
CD8+ T cells which respond to a particular epitope.
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1
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I
1
I
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B C D
Baseline
Precursor
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j
(0) Avidity a
j
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jq
Figure 1: Changing the strength of the cross-reactive cellular adaptive immune response.
Circles represent cells infected with strains 1 and 2; triangles on top of rectangles rep-
resent pMHC complexes; hexagons represent CD8+ T cells. The red epitope is shared
between strains while the blue and yellow epitopes are not. Relative to the baseline case
(A), we can change the number of infected cells required for half-maximal stimulation of
naive/memory CD8+ T cells (kCjq,kCˆjq) and the lysing rate of infected cells by effector
CTL (κEjq, κEˆjq). This is accomplished by changing (B) the initial number (precursor
frequency) of naive CD8+ T cells Cj(0); (C) the avidity of the interaction between the
CD8+ T cell and the pMHC complex which presents the epitope aj ; or (D) the epitope
abundance (the number of pMHC complexes on the surface of the cell) djq.
Given the outstanding immunological uncertainties surrounding the differences be-
tween naive and memory CD8+ T cells (see Section 4), we assume that memory CD8+
T cells Cˆ are identical to naive CD8+ T cells C, such that the effects of memory are
purely due to an increased number of CD8+ T cells after a primary infection. In other
words, we set the parameters kC , κE , βC , nE , τE and δE to be equal to kCˆ , κEˆ , βCˆ , nEˆ ,
τEˆ and δEˆ . In consequence, the change between a primary and secondary infection is
due to initial conditions: Cˆ after a primary infection is greater than C(0), which is true
as long as the number of divisions for effector CTL and the proportion of effector CTL
which become memory CD8+ T cells is not too low, and the death rate of effector CTL
is not too high (results not shown).
Because we are interested in the qualitative behaviour of the model, most parameters
are chosen based on existing literature. Of these, a large number are taken from Cao
et al. (2016), where a similar model for single-strain infection was calibrated to viral load,
antibody and CTL data; we use these model-derived parameters for our study. Other
parameters are chosen such that the time course of a single infection fits the following
criteria based on experimental observations:
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Figure 2: The within-host influenza model illustrated using two strains and one CD8+
T cell pool. (A) Viral dynamics and innate immune response; (B) Humoral adaptive
immune response (shown for virus 1 only; an identical, independent set of compart-
ments exist for virus 2); (C) Cellular adaptive immune response. Solid arrows indicate
transitions between compartments or death (shown only for immune-enhanced death pro-
cesses); dashed arrows indicate production; plus signs indicate an increased transition
rate due to the indicated compartment.
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• The peak viral load occurs at about 2 days post-infection (Laurie et al., 2015)
• The innate immune response is most active 2 –7 days post-infection (Carolan et al.,
2015; Pawelek et al., 2012)
• Antibodies appear after 5 days post-infection and peak at about 20 days post-
infection (Miao et al., 2010)
• CD8+ T cells peak at about 8 days post-infection (Kaech et al., 2002)
• When both humoral and cellular adaptive immune responses are removed, chronic
infection occurs (Iwasaki & Nozima, 1977; Kris et al., 1988)
• When the cellular adaptive immune response is removed, resolution of the infection
is delayed (Hou et al., 1992)
The ordinary differential equations are solved using MatlabR2014b’s ode15s, with
default integration settings. To avoid infections rebounding from unrealistically low
numbers of virions/infected cells, infections are truncated by setting V = I = 0 when
both the number of virions and infected cells drops below 1.
Code to reproduce all of the figures in the study is available at https://ada_yan@
bitbucket.org/ada_yan/cross-reactivity.git.
3. Results
Before presenting detailed results, we first outline the main results of the paper. The
effect of a cross-reactive immune response which allows for effector CTL to differentiate
into memory CD8+ T cells depends on the interval between exposures to the two viruses.
For short inter-exposure intervals (1–3 days), the innate immune response delays a second
infection and reduces shedding relative to a first infection, independent of whether cross-
reactivity and/or memory are present in the cellular adaptive immune response (Fig. 3).
For medium inter-exposure intervals (5–10 days), delayed infection and reduced shedding
are instead due to the cellular adaptive immune response, such that cross-reactivity is
required to delay infection and reduce shedding. For long inter-exposure intervals (10–14
days), both cross-reactivity and memory are required to decrease the recovery time of
the second infection relative to the first, and to boost the number of CD8+ T cells after
a second infection to numbers much larger than for a first infection. The inter-exposure
intervals for which delaying of a second infection, reduced shedding, reduced recovery
time and boosting of CD8+ T cell numbers are observed for the four scenarios explored
in this section are summarised in Fig. 3. We will now discuss each of these effects in
detail.
3.1. The effect of the inter-exposure interval on the outcome of a second infection depends
on the cross-reactivity between strains
In this section, we compare scenarios where there is cross-reactivity between two
strains to scenarios where there is no cross-reactivity. The former is modelled using a
single CD8+ T cell pool which equally responds to the two strains. The parameters are
kC11 = kC12 = kCˆ11 = kCˆ12 = k˜C and κE11 = κE12 = κEˆ11 = κEˆ12 = κ˜E ; the initial
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Inter-exposure interval (days)
2 4 6 8 10 12 14
- cross-react
- memory
- cross-react
+ memory
+ cross-react
- memory
+ cross-react
+ memory
(three
factors
in Sec. 3.2)
shedding ↓
shedding ↓
shedding ↓
shedding ↓
peak time ↑
peak time ↑
peak time ↑
peak time ↑
recovery time ↓, T cell ↑
Sec. 3.1.2, 3.1.3
Sec. 3.1.2
Sec. 3.1.1, 3.1.3
Figure 3: Summary of the effect of the inter-exposure interval, cross-reactivity and mem-
ory on the outcome of the second infection. The bars indicate the inter-exposure intervals
for which the labelled effects are observed, for each scenario on the vertical axis. The
scenarios are (from top) (1) cross-reactivity between the two strains and memory CD8+
T cells present; (2) cross-reactivity but no memory CD8+ T cells; (3) no cross-reactivity
but memory CD8+ T cells present; (4) no cross-reactivity or memory CD8+ T cells. The
yellow bar corresponds to a decrease in shedding; the violet bar corresponds to a delay
in the time to peak viral load relative to a primary infection; the orange bar corresponds
to a decrease in recovery time, as well as an increase in the number of CD8+ T cells
after the second infection relative to the first. The same colours are used for the axis
labels of the relevant quantities in Figs. 6 and 5. For short inter-exposure intervals (1–3
days), reduced shedding and delayed infection are due to the innate immune response,
and are thus independent of whether cross-reactivity and/or memory are present. For
medium inter-exposure intervals (5–10 days), cross-reactivity is required to reduce shed-
ding and delay infection. For long inter-exposure intervals (10–14 days), only the model
with cross-reactivity and memory reduces the recovery time and boosts the number of
CD8+ T cells.
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number of naive CD8+ T cells is C1(0) = C˜(0). The latter is modelled using two CD8
+
T cell pools, each of which only responds to one strain. The parameters are kC11 =
kC22 = kCˆ11 = kCˆ22 = k˜C and κE11 = κE22 = κ˜E ; kC12 = kC21 = kCˆ12 = kCˆ21 = ∞
and κE12 = κE21 = κEˆ12 = κEˆ21 = 0; the initial number of naive CD8
+ T cells is
C1(0) = C2(0) = C˜(0). For each scenario (presence or absence of cross-reactivity), we
compare the sub-cases where effector CTL can become memory CD8+ T cells and where
effector CTL decay without becoming memory CD8+ T cells. The latter is modelled by
setting E = 0.
Figure 4 shows the viral load for two successive infections under three different sets
of assumptions, as detailed in the figure captions. For short inter-exposure intervals
(1–3 days), the innate immune response delays viral kinetics under all three sets of
assumptions. For medium inter-exposure intervals (5–10 days), cross-reactivity further
delays a second infection and reduces shedding. For long inter-exposure intervals (10–
14 days), both cross-reactivity and memory are needed to shorten the second infection.
Figure 5 shows the summary statistics for Fig. 4, which we will now analyse.
3.1.1. For medium inter-exposure intervals, cross-reactivity further delays a second in-
fection and reduces shedding
For medium inter-exposure intervals (5–10 days), the time to peak viral load is delayed
when there is cross-reactivity between the strains, due to the presence of cross-reactive
effector CTL during the exponential growth phase of the second infection. The growth
rate is also slowed down, such that the viral load reaches a smaller value before the
adaptive immune response clears the infection (Fig. 5B), resulting in a smaller area
under the viral load curve (Fig. 5D). The violet and yellow bars in Fig. 3 indicate that
when the cellular adaptive immune response is cross-reactive, the second infection is
delayed and shedding is reduced for a larger range of inter-exposure intervals.
3.1.2. For long inter-exposure intervals, cross-reactivity and memory shorten the recovery
time for a second infection and reduce shedding
When there is no cross-reactivity, for long inter-exposure intervals (> 10 days), the
recovery time for the second infection approaches that of a primary infection (Fig. 5C).
This is due to the temporary nature of the innate immune response, and the cellular
adaptive immune response approaching a steady state. However, when cross-reactivity
and memory CD8+ T cells are present, the recovery time is shortened relative to that for
a primary infection (Fig. 5C). This is consistent with the experimental observations of
Laurie et al. (2015) and Christensen et al. (2000). The area under the viral load curve is
also reduced (Fig. 5D). These results are indicated by the orange bar in Fig. 3. Under our
model where memory cells are functionally identical to naive CD8+ T cells, the advantage
is conferred by having extra memory CD8+ T cells, such that the number of effector CTL
is higher for a second infection, and the lysis rate of infected cells
∑J
j=1(κEjqEj+κEˆjqEˆj)
in Eq. 1c increases.
In the absence of memory CD8+ T cells (but when cross-reactivity is present), the
recovery time for the second infection is in fact slightly longer than for the first infection,
due to the partial depletion of naive CD8+ T cells by the first infection. This confirms
the crucial role of memory CD8+ T cells in shortening the second infection. At initiation
of the second infection, prior to recall of memory CD8+ T cells, the virus is able to
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Figure 4: Viral load for a second infection for three cases: (1) cross-reactivity between
the two strains and memory CD8+ T cells present (black dashed line); (2) cross-reactivity
but no memory CD8+ T cells (magenta dashed line); (3) no cross-reactivity between the
strains (green dashed line). Note: in the case where there is no cross-reactivity between
strains, the time course of the second infection is not changed by the presence of memory
CD8+ T cells. These are compared to what the viral load would have been had the
primary infection been absent (grey area). The grey dotted line indicates the viral load
for the primary infection. Captions indicate inter-exposure intervals.
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Figure 5: The effect of changing the inter-exposure interval on (A) the time to peak viral
load (B) the peak viral load (C) the recovery time (D) the area under the viral load
curve for the second infection. We show the results for three cases: (1) cross-reactivity
between the two strains and memory CD8+ T cells present (black line with crosses);
(2) cross-reactivity but no memory CD8+ T cells (magenta line with circles); (3) no
cross-reactivity between the strains (green line with triangles). These are compared to
the baseline values obtained from a single infection (shaded area). The recovery time
is defined as the time from inoculation to when both the number of infected cells and
the number of virions drops below 1. Note: our definition of recovery time is different
to that by Laurie et al. (2015), where the recovery time was defined as the duration for
which the second virus exceeds an experimental threshold.
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Figure 6: (A) Time course of the total number of CD8+ T cells for a 100-day inter-
exposure interval for four cases: (1) cross-reactivity between the two strains and memory
CD8+ T cells present (black line); (2) cross-reactivity but no memory CD8+ T cells
(magenta line); (3) no cross-reactivity but memory CD8+ T cells (brown line); (4) no
cross-reactivity or memory CD8+ T cells (green line). Note: for the cases without
memory CD8+ T cells, the difference between the cross-reactive and non-cross-reactive
case is due to the choice of initial conditions, whereby the number of CD8+ T cells in
each pool is kept constant, rather than the total number of CD8+ T cells. (B) The total
number of CD8+ T cells 100 days after the second infection, varying the inter-exposure
interval. The total number of CD8+ T cells is defined as
∑J
j=1 Cj +Ej +Mj + Cˆj + Eˆj .
replicate effectively. Then upon recall of memory CD8+ T cells, effector CTL levels grow
to higher levels than the first infection, resulting in faster clearance. For this to be due
to residual effector CTL from the first infection, the time at which the number of effector
CTL peaks would have to be longer than the inter-exposure interval; as CTL peak at
about eight days post-exposure (Kaech et al., 2002), this is not true for longer inter-
exposure intervals. Hence, it is more plausible that a second growth phase of effector
CTL occurs following recall of memory CD8+ T cells.
The result that for long inter-exposure intervals, cross-reactivity and memory are
required to shorten the recovery time for a second infection is robust to changes in model
parameters. A sensitivity analysis for Fig. 5C is presented in Fig. A.10 in Appendix
A.1. The parameters varied are pV , the production rate of virions from cells infected with
either virus; pF , the production rate of interferon from cells infected with either virus; and
κA, the neutralising rate of virions of either strain by antibodies. These parameters vary
viral replication (in the absence of the immune response), the innate immune response,
and the humoral adaptive immune response respectively. Across biologically plausible
ranges of these parameters, both cross-reactivity and memory are required to shorten
the recovery time for a second infection.
3.1.3. A second infection boosts CD8+ T cell numbers when cross-reactivity and memory
are present
When the model does not include memory CD8+ T cells, the total number of CD8+
T cells is slightly less after an infection than before, due to the decay of the CD8+ T
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cells which responded to the infection (Fig. 6A). On the other hand, when the model
includes effector CTL which can become memory CD8+ T cells, infection greatly boosts
the number of CD8+ T cells. When there is no cross-reactivity between the strains, a
separate pool of CD8+ T cells expands and contracts upon the second infection, such
that the final number of cells is roughly twice that for a single infection. On the other
hand, when there is cross-reactivity between the strains, memory cells generated by the
first infection are restimulated, so the CD8+ T cell response to the second infection is
much larger (two orders of magnitude larger than for a single infection).
In this case, as the inter-exposure interval increases, the number of CD8+ T cells
after the second infection increases (Fig. 6B) – the larger the inter-exposure interval, the
more effector CTL from the first infection have differentiated into memory CD8+ T cells,
and so the larger the pool of memory CD8+ T cells which can be induced to proliferate
by a second infection. As indicated by the orange bar in Fig. 3, the number of CD8+ T
cells after the second infection is at least an order of magnitude larger than for the first
infection if (and only if) both cross-reactivity and memory are present, for inter-exposure
intervals 10 days or longer.
For long inter-exposure intervals, the precise duration of the inter-exposure interval
becomes less important because the system approaches a steady state after resolution of
the first infection. The total number of T cells approaches this maximum if the inter-
exposure interval is long enough such that by the second infection, most of the CD8+
T cells stimulated by the first infection have differentiated into memory cells which are
capable of being restimulated. This time roughly corresponds to the sum of the mean
time until naive CD8+ T cell stimulation, the mean total time for effector CD8+ T cell
expansion, the mean time that effector CD8+ T cells spend in their final stage, and the
mean refractory period of memory CD8+ T cells.
The result that the final number of CD8+ T cells after two heterologous infections
is greater when there is cross-reactivity between the two strains is robust to changes in
model parameters, as shown in Fig. A.11 in Appendix A.2.
3.2. Increasing the strength of the cross-reactive response decreases the recovery time for
the second infection, and increases the final number of CD8+ T cells
In the previous section, in the presence of memory CD8+ T cells, we looked at two
simplifying cases:
1. Where a single shared epitope is immunodominant for two strains; and
2. Where the immunodominant epitopes for two strains are distinct (i.e. not shared),
resulting in no cross-reactivity.
However, the overall strength of the cellular adaptive immune response to a single
strain is the sum of the contributions from all of its epitopes. In the context of protection
against subsequent heterologous infection, we are therefore interested in the immune
response to shared epitopes, as the effects of non-shared epitopes are limited to a single
infection.
Accordingly, we now consider the effect of three immunological factors which change
the strength of the immune response for the shared epitope. We model variation in
1. The initial naive T cell number, also known as the precursor frequency (Cj(0));
2. The avidity of the pMHC-T cell interaction (aj); and
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Figure 7: The effect of changing the precursor frequency C1(0) on (A) the recovery time,
(B) the total number of CD8+ T cells 100 days after infection and (C) the expansion
ratio, for the first and second infection. The total number of CD8+ T cells is defined
as C1 + E1 + M1 + Cˆ1 + Eˆ1. The expansion ratio is the ratio between the number of
CD8+ T cells 100 days after an infection, and the number of CD8+ T cells just before
the infection. The inter-exposure interval is fixed at 100 days, chosen to ensure that the
number of CD8+ T cells has settled to a steady state after the first infection. Results
are robust for inter-exposure intervals greater than 20 days (not shown).
3. The epitope abundance per cell infected with either the first or second virus (djq).
These immunological concepts are illustrated in Fig. 1.
These parameters can also be changed for the non-shared epitopes, but this only
affects infection with a single strain. To focus on the effect of changing the immune
response to the shared epitope, we examine the case where there is a single immunodom-
inant epitope which is shared between the strains (i.e. J = 1), and omit the non-shared
epitopes.
3.2.1. Factor 1: The precursor CD8+ T cell frequency
We model the situation where the epitope abundance per infected cell is the same for
both strains, and we vary the initial number of naive CD8+ T cells C1(0) which respond
to the epitope. The avidity of the pMHC-T cell interaction is kept constant, i.e. a1 = 1,
d11 = d12 = 1 (Fig. 1B).
As the precursor frequency C1(0) increases, the recovery time for the first infection
decreases in an exponential-like manner (Fig. 7A), in agreement with the findings of Cao
et al. (2016). The recovery time for the second infection also decreases in an exponential-
like manner. The decrease in recovery time is initially greater for the second infection,
but levels out as the number of precursor CD8+ T cells increases even further, because
the time required for proliferation and differentiation of effector cells becomes a limiting
factor. The recovery time for the second infection is always shorter than that for the
first infection.
For such a long inter-exposure interval, the innate immune response has subsided by
the time of the second infection, so the only difference between the initial conditions
for the two infections is the number of CD8+ T cells available for proliferation and
differentiation into effector CTL.
As the number of precursor CD8+ T cells increases, the total number of CD8+ T cells
after the second infection increases sublinearly (Fig. 7B). This can be analysed in terms
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Figure 8: The effect of changing the avidity a1 on (A) the recovery time, (B) the total
number of CD8+ T cells 100 days after infection and (C) the expansion ratio, for the
first and second infection.
of the expansion ratio (Fig. 7C), defined as the number of CD8+ T cells 100 days after
an infection divided by the number of CD8+ T cells before the infection. For example,
when there are initially 10 CD8+ T cells, each CD8+ T cell results in approximately
120 CD8+ T cells at the end of the first infection; after the second infection, each of
these progeny result in approximately 110 CD8+ T cells (i.e. the total expansion ratio
is 120 × 110 ≈ 104). The expansion ratio is less for the second infection because the
shortened infection decreases the duration and degree of CD8+ T cell stimulation by
infected cells, such that a smaller proportion of initial CD8+ T cells proliferate and
differentiate. This result suggests that the boosting of the immune response by successive
infections yields diminishing returns in terms of the proportion of new CD8+ T cells, if
not their absolute number. This is consistent with the experimental results of Christensen
et al. (2000).
3.2.2. Factor 2: The avidity of the pMHC-T cell interaction
We now model the situation where the epitope abundance per infected cell is the
same for both strains, but we vary the avidity of the pMHC-T cell interaction a1. The
initial number of naive CD8+ T cells which respond to the epitope is kept constant, i.e.
d11 = d12 = 1 and C1(0) = C˜(0) (Fig.1C).
As the avidity a1 increases, the recovery time for both the first and second infections
decrease (Fig. 8A), in a similar manner to Fig. 7A.
The increase in CD8+ T cells which can respond to the second infection relative to
the first is responsible for the decrease in recovery time for a second infection relative
to the first. An additional effect which decreases the recovery time of both the first and
second infection is the increased killing rate of effector CTL (κE12 and κEˆ12 are directly
proportional to a1).
The total number of CD8+ T cells after the second infection increases superlinearly
with avidity (Fig. 8B). This is because the expansion ratios for both infections increase
sublinearly (Fig. 8C), due to two opposing effects on the stimulation rate: a decrease in
the number of infected cells required for half-maximal stimulation (kC12 and kCˆ12), and
a decrease in the recovery time which decreases the number of infected cells available to
stimulate CD8+ T cells. The latter causes the expansion ratio to once again be lower for
the second infection than the first.
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Figure 9: The effect of changing the epitope abundance d1q on (A,D) the recovery time,
(B,E) the total number of CD8+ T cells 100 days after infection and (C,F) the expansion
ratio, for the first and second infection.
3.2.3. Factor 3: The epitope abundance per infected cell
Increasing the epitope abundance per infected cell d1q equally for cells infected with
both viruses (i.e. increasing both d11 and d12) has the same effect as increasing the avidity
a1. The difference between increasing the epitope abundance and increasing the avidity
is that we have assumed that the avidity of the pMHC-T cell interaction remains the
same regardless of strain, whereas the epitope abundance per infected cell can be unequal
for cells infected with different viruses. This is most obviously true when an epitope is
not shared between the two viruses, but even when two strains share an epitope, epitope
abundance per infected cell may differ between strains (Crowe et al., 2003).
We model the situation where the epitope abundance per infected cell d1q differs
between strains, and we keep both the avidity of the pMHC-T cell interaction and the
initial number of naive CD8+ T cells constant, i.e. a1 = a2 = 1 and C1(0) = C˜(0)
(Fig.1D). In the first instance, we vary the epitope abundance per cell infected with
strain 1 (d11) while keeping the epitope abundance per cell infected with strain 2 (d12)
constant; then, we vary d12 while keeping d11 constant, which can be thought of as
reversing the order in which the host is infected.
When the epitope abundance per cell infected with strain 1 (d11) increases, the recov-
ery time for both the first and second infections decrease (Fig. 9A), in a similar manner
to Fig. 7A. Because all parameters for the second virus are held constant, the only dif-
ference for the second infection is the increase in CD8+ T cells available for proliferation
and differentiation due to the first infection (Fig. 9C).
The total number of CD8+ T cells increases sublinearly with the epitope abundance
per cell infected with strain 1 (d11) (Fig. 9B), as a result of the changes in expansion
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ratios (Fig. 9C). The expansion ratio for the first infection increases sublinearly as the
epitope abundance d11 increases, because changing d11 has the same effect on the number
of cells required for half-maximal stimulation of CD8+ T cells (kC11) as changing the
avidity a1. The expansion ratio for the second virus decreases as d11 increases, because
the recovery time, and hence the number of infected cells, decreases, but kC12 and kCˆ12
are constant.
As the epitope abundance per cell infected with the second virus (d12) increases, the
recovery time for the first infection stays constant, since nothing has changed for that
virus. However, the recovery time for the second infection decreases (Fig. 9D) due to
increased stimulation of naive and memory CD8+ T cells (increased kC12 and kCˆ12) and
an increased killing rate for effector CTL (κE12 and κEˆ12).
Changing d12 instead of d11 does not change the total number of CD8
+ T cells after
two infections (Fig. 9E vs. Fig. 9B), but changes the expansion ratio (Fig. 9F). As d12 is
increased, nothing changes for the first infection, while the expansion ratio for the second
infection increases sublinearly.
Summarising Sec. 3.2.1– 3.2.3, when there is a cross-reactive cellular adaptive immune
response, for long inter-exposure intervals, the recovery time for the second infection is
always less than that of the first. Whether we increase the precursor frequency C1(0),
avidity a1 or epitope abundance per infected cell d1q, the recovery time for the second
infection decreases, and the total number of CD8+ T cells after the second infection in-
creases; however, the change in expansion ratio for each infection depends on the factor
changing the immune response. Furthermore, if the strength of the cellular immune re-
sponse is increased equally for both strains (such as by increasing the precursor frequency
or avidity for a common epitope), the expansion ratio for a subsequent infection is less
than for a primary infection.
The result that the recovery time for the second infection decreases as the strength
of the cross-reactive cellular adaptive immune response increases is robust to changes in
model parameters, as shown in Fig. A.12 in Appendix A.3.
4. Discussion
We have constructed a multi-strain model of influenza infection within the host in-
cluding the innate, humoral and cellular adaptive immune responses. The model for the
cellular adaptive immune response includes variable cross-reactivity between strains and
a mechanistic model for differentiation of memory CD8+ T cells. We have used this model
to explain our finding (Laurie et al., 2015) that a shortening of the second infection was
observed when a long interval (10 days or more) separated exposures to heterosubtypic
influenza A strains. As summarised in Fig. 3, both cross-reactivity of the cellular adap-
tive immune response and the differentiation of effector CTL into memory CD8+ T cells
are required to reproduce this shortening of secondary infection. Our experimental de-
sign of successive exposures with heterologous virus with a short inter-exposure interval
enables exploration of the roles of the early innate immune response and the subsequent
adaptive immune response, as well as the roles of transient effector CD8+ T cells and
longer-living memory CD8+ T cells. We anticipate that some of the identifiability issues
which have arisen in previous modelling studies (Smith et al., 2010; Miao et al., 2011;
Boianelli et al., 2015) will be ameliorated with this approach; quantifying cross-reactivity
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and other parameters by fitting our model to the data is the subject of our work in the
immediate future.
We also showed that cross-reactivity in the cellular adaptive immune response delays
the second infection when there is a short interval between exposures. However, in the
case of delayed infection, stochasticity should be taken into account when comparing
the model to experimental data, as suppression of the second virus can manifest as
extinction rather than a delay (Cao et al., 2015; Yan et al., 2016), in line with the
prevented infections observed by Laurie et al. (2015).
In our model, the strength of the immune response can be changed by modifying the
precursor frequency of CD8+ T cells specific to an epitope, the avidity of the pMHC-
T cell interaction and the epitope abundance per infected cell. When an individual is
successively infected with two virus strains which share epitopes recognised by the cellular
adaptive immune response, changing the strength of the immune response in these three
ways impacts the recovery time for both the first and second infection.
Our model predicts that successive infections with heterologous influenza A strains
boost the number of epitope-specific CD8+ T cells, such that cellular adaptive immunity
is strengthened and the recovery time for successive infections decreases. This is sup-
ported by data from mouse experiments (Christensen et al., 2000), but experiments in
other animal systems are lacking. In a previous experiment, Laurie et al. (2010) mea-
sured the viral load time course of up to three successive infections with heterologous
influenza A strains in ferrets; similar experiments including T cell measurements would
be of great benefit in testing our predictions experimentally.
In the case of homologous challenge, the antibodies stimulated by the first exposure
are equally effective against virus introduced by either exposure, resulting in simultaneous
clearance of the virions generated by the first and second exposures (results not shown).
To model this situation, only a single-strain model is needed; the addition of the second
strain manifests as a jump discontinuity in the viral load.
Our model has the flexibility to include multiple shared and non-shared epitopes. This
enables investigation of the emergence of immunodominance, the phenomenon by which
CD8+ T cells specific to one or two epitopes dominate the immune response. We can
either model the expansion of CD8+ T cells specific to epitopes which are experimentally
determined to be dominant, or generate a large range of epitopes with different CD8+ T
cell avidities and abundances. In the latter case, the model would have to be expanded
to take into account that there are many different CD8+ T cell clones which can respond
to a particular epitope with different avidities, as modelled by Chao et al. (2004).
Our work could also be extended to model the changes in epitope-specific CD8+ T
cell numbers over an individual’s lifetime (Quinn et al., 2016), either due to natural
infection or vaccination. Much ongoing work is devoted to the development of next-
generation T cell vaccines which would confer immunity against a wider range of strains
than current antibody based vaccines (Brown & Kelso, 2009). The model would then
need to be adapted to take into account the long-term competition of CD8+ T cell clones
following repeated infections over an individual’s lifetime. The number of CD8+ T cells
in the host is limited, and the total number of memory CD8+ T cells is governed by
homeostasis (Tanchot & Rocha, 1995), causing memory cells produced by new infections
to displace those which are no longer stimulated (Selin et al., 1999). However, in our
model where such considerations are not relevant, increasing the number of infections
increases the number of CD8+ T cells without bound. We could incorporate a saturation
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term (such as that used by Wodarz & Nowak (2000)) into the programmed proliferation
stage, or explicitly model homeostatic regulation (Antia et al., 2005).
Many uncertainties remain about the differences between naive and memory CD8+
T cells in terms of the stimulation threshold required for proliferation and differentiation
into effector CTL, and in terms of how the effector CTL originating from naive and
memory CD8+ T cells differ in parameters such as division rate, total number of divisions,
death rate and functionality. It is clear that memory CD8+ T cells are present in higher
numbers than naive CD8+ T cells after primary infection; they also display lysing ability
within hours of re-exposure to antigen, in contrast to naive CD8+ T cells which gradually
gain functionality over days (Barber et al., 2003; Badovinac & Harty, 2006). However, the
classic assumption that memory CD8+ T cells have a lower stimulation threshold than
naive CD8+ T cells has been questioned (Mehlhop-Williams & Bevan, 2014; Carpenter
et al., 2016). Conventionally, it is also thought that the division rate of memory CD8+
T cells is faster than that of naive CD8+ T cells (Veiga-Fernandes et al., 2000; Veiga-
Fernandes & Rocha, 2004; Badovinac & Harty, 2006), and that a greater proportion of
effector CTL originating from memory CD8+ T cells survive the contraction phase than
do those originating from naive CD8+ T cells (Grayson et al., 2002). However, other
studies have found that when naive and memory CD8+ T cells are co-transferred into
naive hosts before antigen stimulation, naive CD8+ T cells proliferate more quickly than
memory CD8+ T cells (Martin et al., 2012), and that as CD8+ T cells are repeatedly
stimulated, their ability to proliferate decreases (Wirth et al., 2010). It was also found
that a greater proportion of effector CTL originating from naive CD8+ T cells survive
the contraction phase than those originating from memory CD8+ T cells (Martin et al.,
2012).
As a result of this uncertainty it is unclear how the number of infected cells required
for half-maximal stimulation of naive and memory CD8+ T cells, kC and k˜C , and the
lysing rates by naive and memory CD8+ T cells, κE and κ˜E , should differ. Given
that one of the hypotheses for the conflicting results regarding differences between naive
and memory T cells is that the experiments transfer different numbers of naive and
memory CD8+ T cells to the hosts (making initial CD8+ T cell numbers a confounding
factor (Martin et al., 2012)), modelling could potentially resolve the differences between
naive and memory T cell characteristics.
Furthermore, we have assumed that the lysing rate (κE , κEˆ) is directly proportional
to avidity, while the number of infected cells required for half-maximal stimulation of
naive/memory CD8+ T cells (kC , kCˆ) is inversely proportional to avidity. Biologically,
the stimulation threshold for cytolysis is much lower than that for proliferation and
differentiation (Faroudi et al., 2003); we do not know whether the ratio between the two
remains fixed between epitopes, such that they can be described with a single avidity
parameter, as assumed by some previous models (Chao et al., 2004). Furthermore,
because low-avidity CD8+ T cells can still be recruited into the immune response but
cease proliferation prematurely (Zehn et al., 2009), we can model the effect of avidity by
changing the number of proliferation stages nEj rather than the number of infected cells
required for half-maximal stimulation of naive/memory CD8+ T cells (kC , kCˆ). This
does not change the conclusion that increasing the avidity decreases the recovery time
of the second infection and increases the total number of CD8+ T cells after the second
infection (results not shown).
There are other aspects of the cross-reactive cellular adaptive immune response which
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we have not modelled. For example, we have not taken into account different types
of memory CD8+ T cells and their migration patterns in the host. This could not
only influence their activation rate and lysing rate (Shin & Iwasaki, 2013), but could
also introduce delays in lysing activity due to migration time. In fact, a recent study
by Zarnitsyna et al. (2016) has shown that a model including two types of CD8+ T
cells – resident T cells and central memory T cells – can explain the shortening of a
second infection with strains inducing a cross-reactive immune response, with resident
T cells being more effective on a shorter timescale, and central memory T cells acting
on a longer timescale. The delay introduced by migration in the model by Zarnitsyna
et al. (2016) has very similar effects to the refractory memory T cell state in our model,
while resident T cells in the aforementioned model are very similar to effector CD8+
T cells in our model; consequently, our model which does not explicitly include the
location of T cells delivers similar qualitative results to the location-dependent model.
However, quantification of parameters of different types of T cells, including migration
parameters, may prove important for quantitative prediction of infection outcomes and
immune boosting. Moreover, it is of great interest to identify situations in which location
dependence of T cells is essential.
We could also model differing avidity within a pool of CD8+ T cells, and/or extend
our model to include CD4+ T helper cells, which have effects ranging from maintenance
of T cell function (Wherry & Ahmed, 2004) to lysis of infected cells (Brown et al., 2012).
Because CD4+ cells are stimulated by peptide-MHC class II complexes, they are only
activated by professional antigen-presenting cells (Luckheeram et al., 2012); hence, they
are stimulated by different epitopes from CD8+ T cells (Bui et al., 2007), and may be
stimulated to different extents. Our model could be extended to capture different types
of cross-reactivity and their net effect on infection outcomes.
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Parameter Description Value Units
β infection rate of target cells by virions 5× 10−7 (Cao et al., 2016) virion−1 day−1
g target cell regrowth rate 0.8 (Cao et al., 2016) day−1
pV viral production rate 12.6 (Cao et al., 2016) virion infected cell
−1 day−1
pF interferon production rate 1× 10−5 (Cao et al., 2016) uF infected cell−1 day−1
δI infected cell decay rate 2 (Bocharov & Romanyukha, 1994) day
−1
δV virion decay rate 5 (Cao et al., 2016) day
−1
δF interferon decay rate 2 (Pawelek et al., 2012) day
−1
κF killing rate of infected cells by natural killer cells 2.5 (Cao et al., 2016) u
−1
F day
−1
Table 1: Parameter values relating to infection and the innate immune response. uF is an arbitrary unit for the amount of
interferon.
Parameter Description Value Units
pA antibody production rate 0.8 u
−1
B day
−1
δA antibody decay rate 0.04 (Bocharov & Romanyukha,
1994; Lee et al., 2009)
day−1
δB plasmablast and plasma cell decay rate 0.1 (Bortnick & Allman, 2013) day
−1
κA neutralisation rate of virions by antibodies 3 (Miao et al., 2010) (pg/mL)
−1 day−1
kB number of virions for half-maximal stimulation of naive B cells 2× 105 virion
βB maximal stimulation rate of naive B cells 1 day
−1
τB total proliferation time of plasmablasts 3 (Marchuk et al., 1991; Sze
et al., 2000)
day
nB number of plasmablast division cycles 5 (Marchuk et al., 1991; Sze
et al., 2000)
division
Table 2: Parameter values relating to the humoral adaptive immune response. uB is an arbitrary unit for the number of B cells.
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Parameter Description Value Units
k˜C number of infected cells required for half-maximal stimulation of
naive/memory CD8+ T cells (baseline value)
5× 106 infected cells uaud
κ˜E lysing rate of infected cells by effector CTL (baseline value) 3× 10−5 effector cell−1 day−1u−1a u−1d
βC ,βCˆ maximal stimulation rate of naive/memory CD8
+ T cells 1 day−1
δE ,δEˆ decay rate of effector CTL 0.6 (Veiga-Fernandes et al.,
2000)
day−1
τM mean refractory time for memory CD8
+ T cells 14 (Kaech et al., 2002) day
τE ,τEˆ total proliferation time of effector CTL 6 (Lehmann-Grube et al., 1985) day
nE ,nEˆ number of effector CTL division cycles 20 (van Stipdonk et al., 2001) division
 proportion of effector CTL which become (refractory) memory
CD8+ T cells
0.02 (Murali-Krishna et al.,
1998; De Boer et al., 2001; Chao
et al., 2004)
Table 3: Parameter values relating to the cellular adaptive immune response. ua is an arbitrary unit for avidity; ud is an arbitrary
unit for epitope abundance.
Parameter Description Value Units
V (0) virion 10 virion
T (0) target cell 7× 107 (Cao et al., 2015; Petrie et al., 2013) target cell
B0(0) naive B cell 10 uB
C˜(0) naive CD8+ T cell 100 (Blattman et al., 2002) CD8+ T cell
Table 4: Initial values. All unlisted initial values are zero. uB is an arbitrary unit for the number of B cells.
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Appendix A. Sensitivity analysis
We wish to see whether the qualitative relationships between the recovery time for
a second infection and the degree of cross-reactivity in the cellular adaptive immune
response as presented in the main text still hold when model parameters are changed.
To investigate this, we vary chosen parameters one at a time, and reproduce selected
figures from the main text for different values of these parameters. The parameters
varied are
1. pV , the production rate of virions from cells infected with either virus;
2. pF , the production rate of interferon from cells infected with either virus; and
3. κA, the neutralising rate of virions of either strain by antibodies.
These parameters vary three major features of the system: viral replication in the
absence of the immune response, the innate immune response, and the humoral adaptive
immune response. The system features can be varied using other choices of parameters,
although some of these are equivalent in terms of their effect on the viral load. For
example, changing κF while keeping pF constant is equivalent to changing pF while
keeping κF constant; changing pA while keeping κA constant is equivalent to changing
κA while keeping pA constant.
The parameters pV , pF and κA are varied over the ranges [5.0, 101] virion infected
cell−1 day−1, [10−7, 10−4] uF infected cell−1 day−1 and [3 × 10−1, 3 × 107] (pg/mL)−1
day−1 respectively. The lower bound for pV corresponds to R0 ≈ 2, which is the lower
limit of experimentally obtained values of R0 for within-host influenza infection (Smith
& Ribeiro, 2010). Above the upper bound for pV , the number of target cells drops
below one for a single infection, indicating that the probability of target cells becoming
extinct would be high if stochasticity of target cell dynamics were to be taken into
account. Because target cell regrowth is proportional to the number of target cells in the
model, if the number of target cells drops to zero, regrowth does not occur, and a second
infection is not possible. This indicates a likely breakdown in validity of the model in
this region of parameter space. To increase pV while avoiding target cell depletion, we
could simultaneously increase pF , the production rate of interferon from cells infected
with either virus; however, for the purposes of this single-parameter sensitivity analysis,
we exclude this region of parameter space.
Below the lower bound for pF , the number of target cells drops below one for a single
infection, such that a second infection is not possible. (To decrease pF while avoiding
target cell depletion, we could simultaneously decrease pV .) Above the upper bound for
pF , the innate immune response decreases the infected cell and viral load equilibrium
to the point where effective cellular and humoral adaptive immune responses are not
induced, resulting in chronic infection. As we are interested in the dynamics of acute
infection, we consider this region of parameter space biologically implausible and exclude
it from our analysis.
Below the lower bound for κA, the humoral adaptive immune response is not strong
enough to resolve the infection in the absence of the cellular adaptive immune response,
which is at odds with experimental results (Kris et al., 1988; Wells et al., 1981; Yap et al.,
1979).
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Figure A.10: Recovery time for the second infection for a 100-day inter-exposure interval
as the parameter on the x-axis is varied, for four cases: (1) cross-reactivity between
the two strains and memory CD8+ T cells present (black line with crosses); (2) cross-
reactivity but no memory CD8+ T cells (magenta line with circles); (3) no cross-reactivity
between the strains (green line with triangles); (4) no CD8+ T cells (orange line with
crosses). The vertical line indicates the value used for Fig. 5C of the main text. For a
100-day inter-exposure interval, the recovery time for a single infection is the same as
that for the case without cross-reactivity (green line with triangles).
Appendix A.1. For a long inter-exposure interval, cross-reactivity and memory shorten
the recovery time for the second infection
In the main text, we observed that for a long inter-exposure interval (10–14 days),
cross-reactivity and memory are required to shorten the recovery time of a second in-
fection relative to that of a first infection (Fig. 5C). For the purposes of the sensitivity
analysis, we will keep the inter-exposure interval constant at 100 days as pV , pF and κA
are varied.
For all values of pV (Fig. A.10A), pF (Fig. A.10B) and κA (Fig. A.10C), both cross-
reactivity and memory are required to shorten the recovery time of the second infection
relative to the first infection, which indicates that our primary findings are robust to
uncertainty. However, this effect is smaller in some regions of parameter space, such
as when pV , the production rate of virions from infected cells, is high. In this region
of parameter space, the recovery time is hardly affected if the cellular adaptive immune
response is removed (orange line with crosses); this is because the number of infected cells
becomes so large for large values of R0 that target cell depletion becomes the dominant
factor in resolving infection. Similarly, for high values of κA, the recovery time for the
cases with cross-reactivity converge to that for the case without cross-reactivity because
the humoral adaptive immune response efficiently resolves the infection, such that the role
of the cellular adaptive immune response is small. This is evidenced by the little change
in recovery time when the cellular adaptive immune response is removed altogether.
However, in the regions of parameter space where the cellular adaptive immune response
does have a significant effect in resolving infection, cross-reactivity decreases the recovery
time, leaving our conclusions intact.
Appendix A.2. For a long inter-exposure interval, cross-reactivity and memory are re-
quired to boost the total number of CD8+ T cells after the second infection
In the main text, we observed that for a long inter-exposure interval (10–14 days),
both cross-reactivity and memory are required to boost the total number of CD8+ T
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Figure A.11: Total number of CD8+ T cells 100 days after the second infection, for a
100-day inter-exposure interval as the parameter on the x-axis is varied, for four cases:
(1) cross-reactivity between the two strains and memory CD8+ T cells present (black
line with crosses); (2) cross-reactivity but no memory CD8+ T cells (magenta line with
circles); (3) no cross-reactivity but memory CD8+ T cells present (brown line with tri-
angles); (4) no cross-reactivity or memory CD8+ T cells (black line with triangles). The
vertical line indicates the value used for Fig. 6A of the main text. The total number of
CD8+ T cells is defined as C1 + E1 +M1 + Cˆ1 + Eˆ1.
cells after the second infection (Fig. 6A).
For all values of pV (Fig. A.11A) and pF (Fig. A.11B), the total number of CD8
+
T cells after the second infection is boosted when both cross-reactivity and memory are
present, which indicates that our primary findings are robust to uncertainty in these two
parameters.
For low values of κA (Fig. A.11C), the total number of CD8
+ T cells after the second
infection is greater when both cross-reactivity and memory CD8+ T cells are present.
However, for high values of κA, the total number of CD8
+ T cells after the second
infection is marginally greater when the two strains are not cross-reactive. We may
understand this as follows. We have chosen to keep the initial number of naive CD8+
T cells per pool the same (100 cells) in both situations, but in the cross-reactive case,
there is one pool of CD8+ T cells whereas in the non-cross-reactive case, there are two
pools of CD8+ T cells. Hence, the total initial number of CD8+ T cells is greater in the
non-cross-reactive case. For low values of κA, the increased expansion of CD8
+ T cells in
the cross-reactive case compensates for this initial difference. However, when κA is high,
the humoral adaptive immune response efficiently clears the infection, such that only a
small number of CD8+ T cells is stimulated to proliferate and differentiate. Hence, the
initial difference in the total number of CD8+ T cells dominates, and the total number
of CD8+ T cells 100 days after the second infection is less in the cross-reactive case.
However, in this region of parameter space, the expansion of CD8+ T cells in response to
infection, and their effect on the viral load, is unrealistically limited. In contrast, in the
region of parameter space where the cellular adaptive immune response has a significant
effect in resolving infection, our conclusions are robust to parameter uncertainty.
We note that as pV (the production rate of virions from infected cells) increases,
the total number of CD8+ T cells for the second infection increases, then decreases
(Fig. A.11A). This is because as pV increases, the number of infected cells at equilibrium
increases, but the recovery time decreases; the play-off of the two effects causes the areas
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under the two curves
∑Q
q=1 Iq/kCjq
1+
∑Q
q=1 Iq/kCjq
and
∑Q
q=1 Iq/kCˆjq
1+
∑Q
q=1 Iq/kCˆjq
to first increase, then decrease.
The areas under the curves are directly proportional to the number of naive/memory T
cells which proliferate and differentiate during the course of the second infection (follow-
ing from Eq. 3a and Eq. 4a). This results in the total number of CD8+ T cells for the
second infection increasing, then decreasing as pV increases.
Similarly, as pF (the production rate of interferon) increases, the total number of
CD8+ T cells for the second infection decreases (Fig. A.11B) due to a decrease in the
number of infected cells at equilibrium which is not completely offset by a simultaneous
increase in recovery time.
Appendix A.3. The effect of changing the strength of the cross-reactive immune response
on the recovery time for the second infection
In the main text, we described three factors which determine the strength of the cel-
lular adaptive immune response: the precursor CD8+ T cell frequency, the avidity of the
pMHC-T cell interaction, and the epitope abundance on infected cells. We then showed
that increasing the strength of the cellular adaptive immune response by increasing the
parameters corresponding to these three factors (C1(0), a1, d11 and d12) decreases the
recovery time for the second infection (Sec. 3.2).
The conclusion that the recovery time decreases as the strength of the cellular adap-
tive immune response is increased is robust to changes in the production rate of virions
(pV ) (Figs. A.12A-D), although the reduction in recovery time decreases, and finally
becomes negligible, for large values of pV . This is because for large values of pV , resolu-
tion of the infection is driven by target cell depletion rather than the cellular adaptive
immune response. Nevertheless, our conclusions hold in the region of parameter space
where the cellular adaptive immune response has a significant effect on the resolution of
the infection.
The conclusion that the recovery time decreases as the strength of the cellular adap-
tive immune response is increased is robust to changes in the production rate of interferon
from infected cells (pF ) (Figs. A.12E-H). The same conclusion is also robust to changes
in the neutralisation rate of virus by antibodies (κA) (Figs. A.12I-L), although for a
fixed cellular adaptive immune response parameter value (e.g. C1(0)), the relationship
between κA and the recovery time is not monotonic; the shapes of the curves also change
as κA increases.
In detail, in Figures A.12I and K, we see that for a constant non-zero value of C1(0)
and d11, for low values of κA, the recovery time does not change much as κA is changed;
for κA = 3×105 (pg/mL)−1 day−1, the recovery time jumps to a much higher value; and
for κA = 3 × 107 (pg/mL)−1 day−1, the recovery time decreases again. This is because
for high values of κA, the humoral adaptive immune response dominates the resolution of
the infection, preventing sufficient stimulation of the cellular adaptive immune response.
Consequently, for high numbers of precursor CD8+ T cells, increasing κA can actually
increase the recovery time of the second infection, which is consistent with the ‘bump’
shown in Fig. A.10C. The ordering of the lines in Figs. A.12I and K is similar because the
parameters C1(0) (the precursor CD8
+ T cell frequency) and d11 (the epitope abundance
on cells infected with the first virus) both only change the initial conditions for the second
virus rather than rate parameters; the ordering is different for the other two parameters
a1 and d12, but the cause of the non-monotonic ordering is the same. Regardless, for
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Figure A.12: Recovery time for the second virus for a 100-day inter-exposure interval,
as (from top) the precursor frequency C1(0), the avidity a1, the epitope abundance on
cells infected with the first virus d11 and the epitope abundance on cells infected with the
second virus d12 are varied along the x-axes. Different lines correspond to different values
of (left) the production rate of virions from infected cells pV , (centre) the production
rate of interferon from infected cells pF and (right) the neutralisation rate of virions by
antibodies κA, as indicated by the legend. pV , pF and κA are given in units of virion
infected cell−1 day−1, uF infected cell−1 day−1 and (pg/mL)−1 day−1 respectively.
31
each line representing an individual value of κA, increasing each of the cellular adaptive
immune response parameters C1(0), a1, d11 and d12 decreases the recovery time, which
is consistent with the findings in the main text.
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